Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of WWOX/MAF genes on cognitive performance in patients with Parkinson's disease

25 Mar 2025

Abstract excerpt

BACKGROUND: Beyond its hallmark motor symptoms, Parkinson's disease (PD) encompasses a range of non-motor disturbances, particularly cognitive impairment, which significantly affects patients' quality of life. Cognitive impairment is a shared manifest in both PD and Alzheimer's disease (AD), two prevalent neurodegenerative disorders. Existing literature has identified the WWOX/MAF genes as potential risk factors...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetics and Neurodevelopmental Disorders
Share to Nuclear Receptors and Signaling
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40139278
DOI: 10.1016/j.nbd.2025.106887

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of WWOX/MAF genes on cognitive performance in patients with Parkinson's diseasePMID 40139278Read ↗

APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.Semantic proximity Read ↗

Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease.Semantic proximity Read ↗

Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature.Semantic proximity Read ↗

Genetics of cognitive dysfunction in Parkinson's disease.Semantic proximity Read ↗

APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.Semantic proximity Read ↗

Association analyses of Apolipoprotein E genotypes and cognitive performance in patients with Parkinson’s diseaseSemantic proximity Read ↗

Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease.Semantic proximity Read ↗

Investigation of Genetic Variants Associated with Alzheimer Disease in Parkinson Disease Cognition.Semantic proximity Read ↗

Genetic influences on cognitive decline in Parkinson's disease.Semantic proximity Read ↗

Impact of APOE Genotype on Cognition in Idiopathic and Genetic Forms of Parkinson's DiseaseSemantic proximity Read ↗

Clinical and genetic predictors of dementia in Parkinson’s diseaseSemantic proximity Read ↗

Association analyses of apolipoprotein E genotypes and cognitive performance in patients with Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.